Skip to content
PeptideAgent

Are peptides legal in Nebraska?

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The short answer

Yes. A Nebraska resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Nebraska-credentialed prescriber, including by telehealth, because Neb. Rev. Stat. section 38-1,143 lets any credential holder providing a telehealth service prescribe a drug they are otherwise authorized to prescribe. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed in Nebraska; the Nebraska Board of Pharmacy works with the Department of Health and Human Services Licensure Unit, which issues pharmacy licenses, including mail service pharmacy licenses for out-of-state pharmacies shipping into Nebraska.

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Sep 22, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a Nebraska resident get peptides by telehealth?

Neb. Rev. Stat. section 38-1,143, in the Uniform Credentialing Act, provides that a credential holder who is providing a telehealth service to a patient may prescribe the patient a drug if the credential holder is authorized to prescribe under state and federal law, and lets the Department adopt consistent rules. The Nebraska Telehealth Act (Neb. Rev. Stat. sections 71-8501 to 71-8508) sets telehealth consent and coverage rules, mainly for Medicaid. The prescriber must hold a Nebraska credential. Neither statute expressly addresses questionnaire-only asynchronous prescribing, so this record leaves it unconfirmed; the standard of care still applies. None of the peptides in this database are controlled substances. [2] [3]

How does the Nebraska pharmacy board treat compounding?

Compounding regulator for Nebraska
BoardNebraska Board of Pharmacy (licensing through the Department of Health and Human Services, Division of Public Health, Licensure Unit)
Eligible substancesFollows the federal 503A framework

The Nebraska Board of Pharmacy advises the Department of Health and Human Services, which credentials pharmacists under the Pharmacy Practice Act (Neb. Rev. Stat. sections 38-2801 and following) and licenses pharmacies. Under Neb. Rev. Stat. section 71-2407, part of the Mail Service Pharmacy Licensure Act, any person operating a mail service pharmacy outside Nebraska must obtain a Nebraska mail service pharmacy license before shipping, mailing, or delivering dispensed prescription drugs into the state, must hold a valid pharmacy license in its home state, and must employ full time at least one pharmacist holding a Nebraska license who is responsible for compliance. Compounding standards are set by statute: Neb. Rev. Stat. section 38-2867.01 requires anyone authorized to compound to follow USP chapters 795 and 797 as they existed on January 1, 2023, and bars compounding a drug that is essentially a copy of an approved drug unless the Board determines there is a drug shortage or the patient is allergic to the approved drug, and bars compounding any drug FDA or the Board has identified as one that may not be compounded. Nebraska has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [4] [5] [6] [7] [8]

Can you get compounded GLP-1s in Nebraska?

Regulatory: Compounded GLP-1 limited

Nebraska patients using telehealth GLP-1 programs should confirm that the shipping pharmacy holds a Nebraska mail service pharmacy license in the DHHS license lookup. [7] [11]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Nebraska?

Verified access options

Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.

Find a provider in Nebraska

Is it legal to buy research peptides in Nebraska?

The Nebraska Pharmacy Practice Act limits dispensing of prescription drugs to licensed pharmacies and practitioners, so sellers of "research use only" injectable peptides to Nebraska consumers are not lawful dispensers in the state. [4] [12]

Peptide-specific notes for Nebraska

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Can I get a GLP-1 prescription in Nebraska through telehealth?

Yes. Neb. Rev. Stat. section 38-1,143 lets a Nebraska credential holder who is providing telehealth prescribe any drug they are authorized to prescribe, and semaglutide and tirzepatide are not controlled substances. [2]

Who licenses pharmacies in Nebraska?

The Department of Health and Human Services Licensure Unit issues pharmacist credentials and pharmacy licenses, with the Board of Pharmacy advising on standards and discipline. Use the DHHS license lookup to verify a pharmacy. [1] [4]

Can an out-of-state pharmacy ship compounded peptides to me in Nebraska?

Only if it holds a Nebraska mail service pharmacy license from DHHS. If the pharmacy does not appear in the Nebraska license lookup, the shipment is not lawful in Nebraska. [5] [7]

Can a Nebraska pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [8] [9] [10]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.

  1. [1]Nebraska DHHS Licensure Unit: pharmacist and Board of Pharmacy information
  2. [2]Neb. Rev. Stat. section 38-1,143, Telehealth; prescribing
  3. [3]Nebraska Telehealth Act, Neb. Rev. Stat. sections 71-8501 to 71-8508 (DHHS compilation)
  4. [4]Nebraska statutes relating to the Pharmacy Practice Act (DHHS compilation)
  5. [5]Neb. Rev. Stat. section 71-2407, Mail service pharmacy license; requirements; fee
  6. [6]Neb. Rev. Stat. section 38-2867.01, Authority to compound; standards; labeling; prohibited acts
  7. [7]Nebraska DHHS: mail service pharmacy initial license application
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  10. [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
  11. [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  12. [12]21 U.S.C. 331, Prohibited acts

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, September 22). Are peptides legal in Nebraska?. https://peptideagent.ai/legal/nebraska
HTML link
<a href="https://peptideagent.ai/legal/nebraska">Are peptides legal in Nebraska?</a>, PeptideAgent, updated September 22, 2026.